E-viri
Recenzirano
Odprti dostop
-
Bidot, Samuel; Yin, Jun; Zhou, Pengbo; Zhang, Linsheng; Deeb, Kristin K; Smith, Geoffrey; Hill, Charles E; Xiu, Joanne; Bilen, Mehmet A; Case, Katherine B; Tinsley, Mazie; Carthon, Bradley; Harik, Lara R
Archives of pathology & laboratory medicine, 03/2024, Letnik: 148, Številka: 3Journal Article
Genetic profiling data of prostatic adenocarcinoma are derived from predominantly White patients. In African Americans, prostatic adenocarcinoma has a poorer prognosis, raising the possibility of distinct genetic alterations. To investigate the genomic alterations of prostatic adenocarcinoma metastatic to regional lymph nodes in African American patients, with an emphasis on SPOP mutation. We retrospectively reviewed African American patients with pN1 prostatic adenocarcinoma managed with radical prostatectomy and lymph node dissection. Comprehensive molecular profiling was performed, and androgen receptor signaling scores were calculated. Nineteen patients were included. The most frequent genetic alteration was SPOP mutations (5 of 17; 29.4% 95% CI: 10.3-56.0). While most alterations were associated with a high androgen receptor signaling score, mutant SPOP was exclusively associated with a low median and interquartile range (IQR) androgen receptor signaling score (0.788 IQR 0.765-0.791 versus 0.835 IQR 0.828-0.842, P = .003). In mutant SPOP, mRNA expression of SPOP inhibitor G3BP1 and SPOP substrates showed a significantly decreased expression of AR (33.40 IQR 28.45-36.30 versus 59.53 IQR 53.10-72.83, P = .01), TRIM24 (3.95 IQR 3.28-5.03 versus 9.80 IQR 7.39-11.70, P = .008), and NCOA3 (15.19 IQR 10.59-15.93 versus 21.88 IQR 18.41-28.33, P = .046). African American patients with metastatic prostate adenocarcinoma might have a higher prevalence of mutant SPOP (30%), compared to ∼10% in unselected cohorts with lower expressions of SPOP substrates. In our study, in patients with mutant SPOP, the mutation was associated with decreased SPOP substrate expression and androgen receptor signaling, raising concern for suboptimal efficacy of androgen deprivation therapy in this subset of patients.
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.